Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1339039rdf:typepubmed:Citationlld:pubmed
pubmed-article:1339039lifeskim:mentionsumls-concept:C0680730lld:lifeskim
pubmed-article:1339039lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:1339039lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:1339039lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:1339039lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:1339039lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:1339039lifeskim:mentionsumls-concept:C0014441lld:lifeskim
pubmed-article:1339039lifeskim:mentionsumls-concept:C1148554lld:lifeskim
pubmed-article:1339039lifeskim:mentionsumls-concept:C0205349lld:lifeskim
pubmed-article:1339039pubmed:issue4lld:pubmed
pubmed-article:1339039pubmed:dateCreated1993-7-21lld:pubmed
pubmed-article:1339039pubmed:abstractTextAn inhibition ELISA was compared with a modification of the HAVAB assay for measuring antibodies induced by a killed HAV vaccine. GMT's expressed in mIU/ml were higher by ELISA than by modified HAVAB, especially after the first and second doses of vaccine but seroconversion rates were very similar and a good correlation was found between both assays. Because of its higher sensitivity and specificity, the ELISA assay was preferred to modified HAVAB for the evaluation of a Hepatitis A vaccine in human volunteers.lld:pubmed
pubmed-article:1339039pubmed:languageenglld:pubmed
pubmed-article:1339039pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1339039pubmed:citationSubsetIMlld:pubmed
pubmed-article:1339039pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1339039pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1339039pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1339039pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1339039pubmed:statusMEDLINElld:pubmed
pubmed-article:1339039pubmed:monthDeclld:pubmed
pubmed-article:1339039pubmed:issn1045-1056lld:pubmed
pubmed-article:1339039pubmed:authorpubmed-author:DeleoA BABlld:pubmed
pubmed-article:1339039pubmed:issnTypePrintlld:pubmed
pubmed-article:1339039pubmed:volume20lld:pubmed
pubmed-article:1339039pubmed:ownerNLMlld:pubmed
pubmed-article:1339039pubmed:authorsCompleteYlld:pubmed
pubmed-article:1339039pubmed:pagination289-91lld:pubmed
pubmed-article:1339039pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:1339039pubmed:meshHeadingpubmed-meshheading:1339039-...lld:pubmed
pubmed-article:1339039pubmed:meshHeadingpubmed-meshheading:1339039-...lld:pubmed
pubmed-article:1339039pubmed:meshHeadingpubmed-meshheading:1339039-...lld:pubmed
pubmed-article:1339039pubmed:meshHeadingpubmed-meshheading:1339039-...lld:pubmed
pubmed-article:1339039pubmed:meshHeadingpubmed-meshheading:1339039-...lld:pubmed
pubmed-article:1339039pubmed:meshHeadingpubmed-meshheading:1339039-...lld:pubmed
pubmed-article:1339039pubmed:meshHeadingpubmed-meshheading:1339039-...lld:pubmed
pubmed-article:1339039pubmed:meshHeadingpubmed-meshheading:1339039-...lld:pubmed
pubmed-article:1339039pubmed:meshHeadingpubmed-meshheading:1339039-...lld:pubmed
pubmed-article:1339039pubmed:meshHeadingpubmed-meshheading:1339039-...lld:pubmed
pubmed-article:1339039pubmed:meshHeadingpubmed-meshheading:1339039-...lld:pubmed
pubmed-article:1339039pubmed:year1992lld:pubmed
pubmed-article:1339039pubmed:articleTitleComparison of modified HAVAB and ELISA for determination of vaccine-induced anti-HAV response.lld:pubmed
pubmed-article:1339039pubmed:affiliationSmithKline Beecham Biologicals, Rixensart, Belgium.lld:pubmed
pubmed-article:1339039pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1339039pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1339039lld:pubmed